# Emily's Entourage

Emily's Entourage is a Venture Capital based in Merion Station, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Merion Station, United States
- **Address:** Merion Station, United States
- **Assets under management:** Undisclosed
- **Website:** www.emilysentourage.org
- **LinkedIn:** https://www.linkedin.com/company/emilysentourage

## Regulatory record

- **Reports private funds:** No

## About

Emily’s Entourage is a venture philanthropy-focused nonprofit organization headquartered in Merion Station, United States. It raises money and awareness to fund research, grants, venture philanthropy investments, and clinical trial initiatives. Its work is dedicated to finding treatments and a cure for rare mutations of cystic fibrosis affecting the final 10% of patients. The organization directs capital toward scientific research and clinical advancement within this specialized therapeutic area. Its investment approach blends grant-making with venture philanthropy to accelerate development of therapeutics for underserved cystic fibrosis populations. The firm’s strategy centers on catalytic funding aimed at closing gaps in rare disease research and drug development. Specific fund sizes, portfolio companies, and assets under management are not disclosed in the available information.

## Sectors

- Venture Capital
- United States

## Questions

### What is Emily’s Entourage?

Emily’s Entourage is a nonprofit organization that raises money and awareness to fund research, grants, venture philanthropy investments, and clinical trial initiatives aimed at finding treatments and a cure for rare mutations of cystic fibrosis affecting the final 10% of patients.

### Where is Emily’s Entourage headquartered?

Emily’s Entourage is headquartered in Merion Station, United States.

### What is Emily’s Entourage’s investment strategy?

It combines grants, venture philanthropy investments, and clinical trial funding to accelerate research and therapeutic development for rare cystic fibrosis mutations affecting the final 10% of patients.

---

Last updated: 2026-07-13T03:16:27.000Z

Canonical page: https://altss.com/profile/emily-s-entourage

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology